Almira I. Baigalkanova

Almira I. Baigalkanova

Auto-generated profile, based on publicly available information

Almira I. Baigalkanova

CF «University Medical Centre», Astana, Republic of Kazakhstan

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2025 in West Kazakhstan Medical Journal
Verified
Journal Article
Closed access
PDF file
AAAinamkoz K. Amanzholova
Ainamkoz K. Amanzholova
MMMarina A. Morenko
Marina A. Morenko
BBBolat E. Bekishev
Bolat E. Bekishev
TITatyana Ivanova-Razumova
Tatyana Ivanova-Razumova
ABAlmira I. Baigalkanova
Almira I. Baigalkanova
DKDariga K. Koichubayeva
Dariga K. Koichubayeva
The problem of acute kidney injury (AKI) in children undergoing cardiac surgery remains relevant even in the presence of modern medical technologies and methods. This complication, which occurs after pediatric cardiac surgery, has significant negative consequences, leading to the patient staying in the infant intensive care unit (IICU) for a longer period and even an increased risk of death. According to the literature, cardiac surgery-associated acute kidney injury (CSAKI) is a common complication after surgery to correct congenital heart defects in children, with a reported incidence rate of up to 42%. This fact is increasingly recognized as a serious problem affecting the health of pediatric patients. The aim of the study is to analyze modern concepts concerning the impact of cardiac surgery on the development of acute kidney injury in children, and to, identify the main trends and current scientific ideas about the mechanisms which form this complication in pediatric cardiac surgery. The review was compiled using literature search methods in databases such as Scopus, PubMed, MedLine, Cyberleninka, Google Scholar, Cochrane Library, and TripDataBase, covering the period from 2014 to 2024. Scientific studies aimed at identifying risk factors for the development of acute kidney injury in children after cardiac surgery have identified a number of important aspects, including the age of the patients, the duration of cardiopulmonary bypass, the level of surgical complexity of the operation, the need for mechanical ventilation, and inotropic support. Despite significant achievements in this area, some aspects remain under-researched. As the use of substitutive renal therapy as part of the comprehensive treatment of acute renal failure is increasing, understanding these problems becomes more urgent.

28 January 2026 in Наука и здравоохранение
Verified
Journal Article
Closed access
ABA.I. Baygalkanova
A.I. Baygalkanova
SAS.T. Abdrakhmanova
S.T. Abdrakhmanova
AMAssylzhan Messova
Assylzhan Messova
GBG.K. Besbayeva
G.K. Besbayeva
ATAliya Tuleubayeva
Aliya Tuleubayeva
Introduction. The investigation of cardiorenal syndrome holds significant clinical relevance, as both cardiovascular and renal diseases rank among the leading causes of mortality. Current research efforts are focused on identifying reliable biomarkers for the early detection of acute kidney injury (AKI), which may serve as a valuable predictor for improving prognosis and therapeutic strategies in patients with chronic heart failure. The study aims to identify biomarkers associated with an increased risk of type 2 cardiorenal syndrome in children. Materials and methods. We performed a retrospective analysis with a case-control design. From the medical records of the Scientific National Cardiac Surgery Center (NNCC), we identified all pediatric patients with CHF due to DCM who had an initial hospitalization in 2022 and a subsequent re-hospitalization in 2023. Based on their diagnosis at re-hospitalization, patients were classified into two groups: the case group (those with confirmed Type 2 CRS, n=18) and the control group (those with CHF but without CRS, n=21). We then extracted and compared laboratory data from both the 2022 (baseline) and 2023 (follow-up) hospitalizations for all participants. Results. Reduced serum iron levels were observed at baseline and during follow-up in both the control and case groups (9 and 5.9 µmol/L, respectively). Elevated total bilirubin levels were also detected in both groups (0.41 µmol/L in controls and 0.55 µmol/L in cases). Notably, galectin-3 concentrations were elevated in the case group, showing a 13% increase compared to the control group. Markers of renal dysfunction, including the albumin-to-creatinine ratio (ACR) and the blood urea nitrogen-to-creatinine (BUN/Cr) ratio, were comparable between the two groups (ACR: 31 and 32 mg/g; BUN/Cr: 30 and 32, respectively). Statistically significant correlations were identified between kidney function (as measured by ACR) and levels of serum iron (p=0.05), hemoglobin (p=0.02), and galectin-3 (p=0.02). Galectin-3 was a significant predictor of renal dysfunction, with an 81% increase in the likelihood of renal dysfunction (OR = 1.81, 95% CI). Similarly, the BUN/Cr ratio was associated with a 70% increase in the likelihood of renal impairment (OR = 1.70, 95% CI). Conclusion. The findings indicate that, despite similar baseline values of key renal markers across groups, galectin-3 levels were significantly elevated in cases and were strongly associated with renal dysfunction. Reduced serum iron and elevated bilirubin levels were observed in both groups, suggesting potential systemic involvement. However, the small sample size limits the statistical power and generalizability of these findings, warranting validation in larger, prospective cohorts. Введение. Исследование кардиоренального синдрома имеет важное клиническое значение, поскольку как сердечно-сосудистые, так и почечные заболевания входят в число основных причин смертности. Текущие исследовательские усилия сосредоточены на выявлении надежных биомаркеров для раннего выявления острого повреждения почек (ОПП), которые могут служить ценным предиктором для улучшения прогноза и терапевтических стратегий у пациентов с хронической сердечной недостаточностью. Целью исследования является выявление биомаркеров, связанных с повышенным риском кардиоренального синдрома 2 типа. Материалы и методы. Было проведено ретроспективное исследование типа «случай-контроль» с участием пациентов с подтвержденным диагнозом кардиоренального синдрома (КРС) 2-го типа (n=18) во время первичной госпитализации в 2022 г. и последующей повторной госпитализации в 2023 г., которые составили группу случая. Контрольная группа включала пациентов с хронической сердечной недостаточностью (ХСН), но без клинических или лабораторных признаков КРС 2-го типа (n=21). Результаты. Снижение уровня сывороточного железа наблюдалось на исходном уровне и во время последующего наблюдения как в группе контроля, так и в группе случая (9 и 5,9) мкмоль/л соответственно). Повышенные уровни общего билирубина также были обнаружены в обеих группах (0,41 мкмоль/л в контрольной группе и 0,55 мкмоль/л в случаях). Примечательно, что концентрации галектина-3 были повышены в группе случая, показывая 13%-ное увеличение по сравнению с контрольной группой. Маркеры почечной дисфункции, включая соотношение альбумина к креатинину (ACR) и соотношение азота мочевины крови к креатинину (BUN/Cr), продемонстрировали сопоставимые значения в обеих группах (ACR: 31 и 32 мг/г; BUN/Cr: 30 и 32 соответственно)....